Cannara Biotech Stock Cash Per Share
| LOVE Stock | CAD 0.75 0.05 6.25% |
Cannara Biotech fundamentals help investors to digest information that contributes to Cannara Biotech's financial success or failures. It also enables traders to predict the movement of Cannara Stock. The fundamental analysis module provides a way to measure Cannara Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cannara Biotech stock.
| Last Reported | Projected for Next Year | ||
| Cash Per Share | 0.07 | 0.07 |
Cannara | Cash Per Share |
Cannara Biotech Company Cash Per Share Analysis
Cannara Biotech's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current Cannara Biotech Cash Per Share | 0.01 X |
Most of Cannara Biotech's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cannara Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cannara Cash Per Share Driver Correlations
Understanding the fundamental principles of building solid financial models for Cannara Biotech is extremely important. It helps to project a fair market value of Cannara Stock properly, considering its historical fundamentals such as Cash Per Share. Since Cannara Biotech's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cannara Biotech's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cannara Biotech's interrelated accounts and indicators.
Click cells to compare fundamentals
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
Cannara Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
In accordance with the recently published financial statements, Cannara Biotech has a Cash Per Share of 0.01 times. This is 99.77% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The cash per share for all Canada stocks is 99.8% higher than that of the company.
Cannara Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cannara Biotech's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cannara Biotech could also be used in its relative valuation, which is a method of valuing Cannara Biotech by comparing valuation metrics of similar companies.Cannara Biotech is currently under evaluation in cash per share category among its peers.
Cannara Biotech Current Valuation Drivers
We derive many important indicators used in calculating different scores of Cannara Biotech from analyzing Cannara Biotech's financial statements. These drivers represent accounts that assess Cannara Biotech's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Cannara Biotech's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 67.8M | 130.1M | 118.4M | 61.2M | 70.4M | 128.1M | |
| Enterprise Value | 72.9M | 142.8M | 154.6M | 103.0M | 118.4M | 143.2M |
Cannara Fundamentals
| Return On Equity | 0.0678 | ||||
| Return On Asset | 0.0378 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 113.72 M | ||||
| Shares Outstanding | 90.02 M | ||||
| Shares Owned By Insiders | 49.42 % | ||||
| Number Of Shares Shorted | 10 | ||||
| Price To Book | 0.82 X | ||||
| Price To Sales | 0.94 X | ||||
| Revenue | 57.26 M | ||||
| Gross Profit | 17.33 M | ||||
| EBITDA | 14.29 M | ||||
| Net Income | 6.95 M | ||||
| Cash And Equivalents | 5.56 M | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 5.97 M | ||||
| Debt To Equity | 0.45 % | ||||
| Current Ratio | 2.95 X | ||||
| Book Value Per Share | 0.91 X | ||||
| Cash Flow From Operations | 5.44 M | ||||
| Short Ratio | 0.03 X | ||||
| Earnings Per Share | 0.07 X | ||||
| Beta | 1.07 | ||||
| Market Capitalization | 72.02 M | ||||
| Total Asset | 141.52 M | ||||
| Retained Earnings | (19.34 M) | ||||
| Working Capital | 30.51 M | ||||
| Net Asset | 141.52 M |
About Cannara Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cannara Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cannara Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cannara Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cannara Stock Analysis
When running Cannara Biotech's price analysis, check to measure Cannara Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannara Biotech is operating at the current time. Most of Cannara Biotech's value examination focuses on studying past and present price action to predict the probability of Cannara Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannara Biotech's price. Additionally, you may evaluate how the addition of Cannara Biotech to your portfolios can decrease your overall portfolio volatility.